Negotiating Price Negotiation: Why the Democrats Will Struggle to Pressure Part D Prices

The new Congress wants to make federal price negotiation under Medicare a reality. But it won't be easy. Big Pharma should expect plenty of interference from the Democrats in Part D, but it is hard to see a meaningful impact on prices in the near term.

By Michael McCaughan

Acting Centers for Medicare & Medicaid Services director Leslie Norwalk has a question: if the federal agency is told the...

More from Market Access

More from Pink Sheet